Aim and Methods: Although the antimicrobial activity of extracts from several mushroom species have been reported, studies with the individual compounds present in that extracts are scarce. Herein, the antimicrobial activity of different phenolic compounds identified and quantified in mushroom species from all over the world was evaluated. Furthermore, a structure activity relationship (SAR) analysis and molecular docking studies were performed, in order to provide insights in the mechanism of action of potential antimicrobial drugs for resistant microorganisms.
Introduction
In recent years, there is an increasing number of reports on phenolic compounds in different mushroom species. Phenolic acids including benzoic and cinnamic acid derivatives have been pointed out as the most common. Among benzoic acid derivatives, p-hydroxybenzoic, protocatechuic, gallic, vannilic and syringic acids were identified in different mushroom species (Puttaraju et al. 2006; Kim et al. 2008; Barros et al. 2009; Heleno et al. 2011; Reis et al. 2011; Vaz et al. 2011; Heleno et al. 2012) ( Table 1 ). The identification of cinnamic acid and its derivatives such as p-coumaric, ocoumaric, caffeic, ferulic and chlorogenic acids was also described (Mattila et al. 2001; Valentão et al. 2005; Puttaraju et al. 2006; Barros et al. 2008; Kim et al. 2008; Heleno et al. 2011; Reis et al. 2011; Vaz et al. 2011; Heleno et al. 2012) . The presence of some Although the antimicrobial activity of extracts from several mushroom species have been reported (Barros et al. 2007; Quereshi et al. 2010; Ozen et al. 2011; Alves et al., 2012) , studies with the individual compounds present in that extracts are scarce, being mainly related to phenolic compounds identified in plant sources (Kuete et al. 2009; Orhan et al. 2010; Lou et al. 2012) .
Therefore, the aim of the present study was to evaluate the antimicrobial activity of most relevant compounds identified and quantified in mushroom species from all over the world. Furthermore, a structure activity relationship (SAR) analysis and molecular docking studies against Penicillin Binding Protein 2a (PBP2a) were performed, in order to give insights in the mechanism of action of potential antimicrobial drugs for resistant microorganisms. Molecular docking is an in silico tool that predicts how a ligand (substrate or drug candidate) interacts with a receptor (e.g. proteins involved in several biological processes) and has been successfully applied in several therapeutic programs at the lead discovery stage (Ghosh et al. 2006) . ampicillin, while MRSA was resistant to oxacillin, levofloxacin and ciprofloxacin;
Staphylococcus epidermidis showed resistance to oxacillin and erythromycin.
All strains were identified using the MicroScan automated methodology -Siemens.
Muller Hinton broth (MHB) and Wilkins-Chalgren Broth (WCB) were used for determination of Minimum Inhibitory Concentration (MIC, lowest concentration of the phenolic compound able to completely inhibit bacterial growth).
Test assays for antimicrobial activity
MIC determinations were performed by the microdilution method and the rapid piodonitrotetrazolium chloride (INT) colorimetric assay following the methodology suggested by Kuete et al. (2011) with some modifications.
Initially, 50 µL of each phenolic compound solution (1mg/mL) filter sterilized was diluted in 450 µL of MHB for all microorganisms except for Neisseria gonorheia where WCB was used (also with final concentration of 1 mg/mL) and then, 200 µL of this solution was added in each well (96-well microplate). Titrations (eight different final concentrations) were carried out over the wells containing 100 µL of MHB or WCB and afterwards, 10 µL of inoculum (1 ×10 8 cfu/mL) were added to all the wells.
Two negative (one with MHB or WCB and the other with the phenolic compound) and one positive (with MHB or WCB and the inoculum) controls were performed. The plates were incubated at 37 °C, for 24 h, in an oven (Jouan, Berlin, Germany) or with humidified atmosphere containing 10% CO 2 (NuAire, Plymouth, USA), in the case of
Neisseria gonorrhoeae.
The MIC of the samples were detected following addition of INT (0.2 mg/mL, 40 µL) and incubation at 37 °C for 30 min. Viable microorganisms reduced the yellow dye to a pink colour. MIC was defined as the lowest phenolic compound concentration that prevented this change and exhibited complete inhibition of bacterial growth. All the assays were carried out in duplicate.
Compounds and protein structure preparation ACD/ChemSketch Freeware 12.0 software was used to design 2D structure of the compounds. The software VegaZZ 2.3.1 (Pedretti et al. 2004) was then used to convert all compounds from 2D to 3D structures. AutoDockTools1.5.2 (ADT) (Sanner 2005) was used to merge nonpolar hydrogens, add Gasteiger charges, and set up rotatable bonds through AutoTors. AutoDockTools was also used to assign polar hydrogens, add gasteiger charges and save the protein structure in PDBQT file format. AutoGrid4 (Morris et al. 2009 ) was used to create affinity grid maps for all the atoms on the protein and phenolic compounds used.
Molecular docking
AutoDock4 (version 4.2) with the Lamarckian genetic algorithm was used to perform the docking studies. Docking parameters selected for AutoDock4 runs were as follows:
100 docking runs, population size of 200, random starting position and conformation, translation step ranges of 2.0 Å, mutation rate of 0.02, crossover rate of 0.8, local search rate of 0.06, and 2.5 million energy evaluations. Docked conformations were clustered using a tolerance of 2.0 Å RMSD (Root Mean Square Deviation). The molecular docking experiments were performed on a dedicated cluster of 64 Core AMD 2.0 GHz, running on CentOS and using MOLA, a custom designed software for virtual screening using AutoDock (Abreu et al. 2010 ). All figures with structure representations were produced using PyMOL (The PyMOL Molecular Graphics System, Version 1.3, Schrödinger, LLC. Available at: (http://www.pymol.org/). Table 1 presents phenolic compounds that have been identified in different mushroom species from several countries, where it can be observed that different compounds were detected in the same species. Several external factors have been pointed to explain this fact, such as the heterogeneous enzymatic and oxidative decomposition after collection, different stress conditions associated to each sample, and even dissimilar methodologies applied to phenolic compounds extraction (Oke and Aslim 2011; Vaz et al. 2011 ).
Results
These compounds are well known for their antioxidant properties (Puttaraju et al. 2006; Ribeiro et al. 2007; Kim et al. 2008 ), but they also revealed antimicrobial activity (Barros et al. 2007; Quereshi et al. 2010; Schwan et al. 2010; Ozen et al. 2011) emerging with potential against multiresistances. Their increasing prevalence is one of the major challenges for the healthcare systems worldwide. Antibiotic resistant infections are associated with a 1.3 to 2-fold increase in mortality compared to antibiotic susceptible infections (Cosgrove and Carmeli 2003) . Moreover, antibiotic resistance imposes enormous health expenditure due to the higher treatment costs and longer hospital stays. In addition, the development of new generations of antibiotic drugs is stalling.
In the present study, in the range of tested concentrations (0.78-1000 µg/mL), 2,4-dihydroxybenzoic, protocatechuic, vanillic and p-coumaric acids showed antibacterial activity (MIC=1 mg/mL) against Escherichia coli, Pasteurella multocida and Neisseria gonorrhoeae ( while the ones used in the mentioned study did not revealed relevant resistances; this important feature could be related to the differences observed in MIC values.
Despite the absence of reports regarding the presence of 2,4-dihydroxybenzoic acid in mushrooms and its antimicrobial activity, due to the chemical similarity with other phenolic acids mentioned as antimicrobial compounds, we decided to test it and, as far as we know this is the first report on its activity against Gram negative bacteria.
Gallic acid, ferulic acid and quercetin exhibited activity only against Pasteurella multocida and Neisseria gonorrhoeae, and the latter was mainly sensible to quercetin (MIC=0.5 mg/mL; is an emergent resistance of this bacteria to the antimicrobial agents used in gonorrhea treatment. Therefore, the mentioned phenolic compounds could be an alternative to be explored for the control of this infection. Studies evaluating the antibacterial activity of mushroom extracts or isolated compounds against Neisseria gonorrhoeae are scarce, so it is important to clarify their mechanism of action upon this microorganism as also in other Gram negative cocci.
Although no activity was observed for rutin against the tested Gram negative bacteria ( Once more, 2,4-dihydroxybenzoic and protocatechuic acid were the phenolic compounds with higher activity against the majority of Gram positive bacteria (Table   3) . Protocatechuic acid showed a MIC of 1 mg/mL for MSSA and MRSA, as also for have some inherent toxicity and should be carefully used.
Syringic and ellagic acids showed a MIC of 0.5 mg/mL against Listeria monocytogenes (Table 3) . Cinnamic acid seemed to be the most active upon Steptococcus agalactiae (CMI 0.5 mg/mL) Among all the tested phenolic compounds, only 2,4-dihydroxybenzoic acid inhibited Enterococcus faecalis (MIC=1 mg/mL); nonetheless, other authors described antimicrobial activity of rutin (MIC=128 mg/mL), protocatechuic acid (MIC=39 µg/mL) and vanillic acid (zone of inhibition 16 mm) (Kuete et al. 2009; Orhan et al. 2010; Teke et al. 2011) . Isolates of Enterococcus faecalis and Enterococcus faecium are the third-to fourth-most prevalent nosocomial pathogen worldwide; acquired resistance, most prominently to penicilin/ampicillin, aminoglycosides (high-level resistance) and glycopeptides are reported in an increasing number of isolates, and the therapeutic spectrum in these cases is limited. Therefore, therapeutic alternatives to treat infections with multi-and vancomycin-resistant enterococci (VRE) are restricted to antibiotics introduced recently into clinical practice such as quinupristin/dalfopristin, linezolid, tigecyclin and daptomycin. However, these drugs are only approved for certain indications and resistance has already been reported (Montero et al. 2008; Werner et al. 2008) , which emphasizes the importance of the discovery of new alternative drugs.
It should be notice that the differences among the results reported by several authors could be related to the use of strains with different resistance profiles, but also to different methodologies used including different solvents for compound solution preparation or different techniques to determine MICs. In the present study, water was chosen for being the most innocuous solvent; however in the case of flavonoids and tannins water with 1% DMSO was used to assure the total solubility of the compounds.
MRSA has been indicated as one of the major causes of nosocomial infections and its increasing prevalence has been observed in the last decade. Furthermore, the treatment of MRSA infections is difficult due to the restrict spectra of efficient antibiotics (Chambers et al. 2001) . The obtained data in the present study (Table 3) show that phenolic compounds inhibited more MRSA than methicillin sensible Staphylococcus aureus. MRSA was inhibited by 2,4-dihydroxybenzoic, vanillic, syringic (MICs=0.5 mg/mL) and p-coumaric (MIC= 1 mg/mL) acids, while these compounds at the same concentrations had no inhibitory effects against methicillin sensible Staphylococcus aureus. Ferulic acid inhibited both MRSA and methicillin sensible Staphylococcus aureus, but in a lower concentration for MRSA ( Table 3) .
Discussion
Regarding these results, it is interesting to notice that the two Staphylococcus aureus tested showed different susceptibility toward the compounds tested, possibly explained by the different resistance mechanisms exhibited by each strain. To understand theses differential effects, a structure-activity relationship (SAR) study was carried by analysing the different chemical structure patterns of the evaluated compounds.
Only phenolic acids (benzoic and cinnamic acid derivatives) showed activity, highlighting the importance of the carboxylic group in the molecule structure (proton acceptor). Furthermore, all the compounds with anti-MRSA activity have OH (proton donor) and OCH 3 (proton acceptor) groups in the para and meta positions of the benzene ring, respectively (Table 4 ).In the absence of OCH 3 group in the meta position (p-coumaric acid), the activity decreased. Nevertheless, the absence of the mentioned group in the structure of 2,4-dihydroxybenzoic acid seemed to be overlapped by the OH substitution in ortho position of the benzene ring. Only OCH 3 (proton acceptor) or H in position 5 of the benzene ring allowed anti-MRSA activity, since when OH is presented in that position the activity disappears (see the examples of protocatechuic and gallic acids in Table 4 ).
MRSA is resistant to all β-lactam antibiotics and this ability is due to the acquisition of mecA gene (Lowy 2003) . This gene encodes the PBP2a protein and when it is challenged by β-lactams, MRSA will use the transpeptidase functionality of PBP2a to synthesize the cell wall (Wilke et al. 2005) .
Since the major difference between MSSA and MRSA is mecA, studies of molecular docking were performed using 3D crystal structure of PBP2a ( The presence of carboxylic acid (COOH), two hydroxyl (OH) groups in para and ortho positions of the benzene ring, as also a methoxyl (OCH 3 ) group in the meta position seems to play an important role in the studied phenolic compounds anti-MRSA activity.
The docking studies provided strong evidence that the molecular basis for this activity is probably as PBP2a inhibitors. The mentioned compounds could be a solution for multiresistance problem, but their mechanism of action in different microorganisms should be better understood. 
